127 related articles for article (PubMed ID: 32870062)
21. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
[TBL] [Abstract][Full Text] [Related]
22. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of cytogenetic characteristics in patients with myelodysplastic syndrome].
Ma L; Zhong MH; Han CW; Wang JY; Cao YT; Ma YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1405-9. PubMed ID: 23257442
[TBL] [Abstract][Full Text] [Related]
24. Myelodysplastic syndrome associated with trisomy 2.
Heller M; Provan D; Amess JA; Dixon-McIver A
Clin Lab Haematol; 2005 Aug; 27(4):270-3. PubMed ID: 16048496
[TBL] [Abstract][Full Text] [Related]
25. Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH study.
Andersen MK; Christiansen DH; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2005 Apr; 42(4):358-71. PubMed ID: 15645489
[TBL] [Abstract][Full Text] [Related]
26. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
[TBL] [Abstract][Full Text] [Related]
27. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.
Xu W; Li JY; Liu Q; Zhu Y; Pan JL; Qiu HR; Xue YQ
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e86-95. PubMed ID: 20089000
[TBL] [Abstract][Full Text] [Related]
28. [Cytogenetics of myelodysplastic syndromes and its impact as prognostic factor].
Borjas-Gutiérrez C; Domínguez-Cruz MD; González-García JR
Rev Med Inst Mex Seguro Soc; 2017; 55(4):481-489. PubMed ID: 28591503
[TBL] [Abstract][Full Text] [Related]
29. Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis.
Zemanova Z; Michalova K; Buryova H; Brezinova J; Kostylkova K; Bystricka D; Novakova M; Sarova I; Izakova S; Lizcova L; Ransdorfova S; Krejcik Z; Merkerova MD; Dohnalova A; Siskova M; Jonasova A; Neuwirtova R; Cermak J
Leuk Res; 2014 May; 38(5):537-44. PubMed ID: 24636338
[TBL] [Abstract][Full Text] [Related]
30. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
Mecucci C
Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes.
Duong VH; Padron E; Al Ali NH; Lancet JE; Hall J; Kwok B; Zhang L; Epling-Burnette PK; List AF; Komrokji RS
Ann Hematol; 2018 Feb; 97(2):247-254. PubMed ID: 29167940
[TBL] [Abstract][Full Text] [Related]
33. Balanced translocations in myelodysplastic syndromes (MDS) - an unrecognised MDS patient subgroup?
Mittelman M
Br J Haematol; 2020 Jul; 190(2):141-142. PubMed ID: 32243579
[No Abstract] [Full Text] [Related]
34. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes.
Saumell S; Florensa L; Luño E; Sanzo C; Cañizo C; Hernández JM; Cervera J; Gallart MA; Carbonell F; Collado R; Arenillas L; Pedro C; Bargay J; Nomdedeu B; Xicoy B; Vallespí T; Raya JM; Belloch L; Sanz GF; Solé F
Br J Haematol; 2012 Nov; 159(3):311-21. PubMed ID: 22958186
[TBL] [Abstract][Full Text] [Related]
36. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop.
Slovak ML; Bedell V; Popplewell L; Arber DA; Schoch C; Slater R
Genes Chromosomes Cancer; 2002 Apr; 33(4):379-94. PubMed ID: 11921272
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registry.
Diamantopoulos P; Koumbi D; Kotsianidis I; Pappa V; Symeonidis A; Galanopoulos A; Zikos P; Papadaki HA; Panayiotidis P; Dimou M; Hatzimichael E; Vassilopoulos G; Delimpasis S; Mparmparousi D; Papageorgiou S; Variami E; Kyrtsonis MC; Megalakaki A; Kotsopoulou M; Repousis P; Adamopoulos I; Kontopidou F; Christoulas D; Kourakli A; Tsokanas D; Konstantinos Papoutselis M; Kyriakakis G; Viniou NA;
Cancer Med; 2019 May; 8(5):2056-2063. PubMed ID: 30897290
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of monosomal karyotype in myelodysplastic syndrome: a meta-analysis.
Wu YC; Zhang XM; Zhu YD; Wu W
Hematology; 2019 Dec; 24(1):60-69. PubMed ID: 30129389
[TBL] [Abstract][Full Text] [Related]
39. Monosomal karyotype predicts inferior survival independently of a complex karyotype in patients with myelodysplastic syndromes.
McQuilten ZK; Sundararajan V; Andrianopoulos N; Curtis DJ; Wood EM; Campbell LJ; Wall M
Cancer; 2015 Sep; 121(17):2892-9. PubMed ID: 26043022
[TBL] [Abstract][Full Text] [Related]
40. Unbalanced translocation der(11)t(11;12)(q23;q13): a new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype.
Yamamoto K; Hato A; Minagawa K; Yakushijin K; Urahama N; Gomyo H; Sada A; Okamura A; Ito M; Matsui T
Cancer Genet Cytogenet; 2004 Nov; 155(1):67-73. PubMed ID: 15527905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
